A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

In 2023, the Centers for Medicare and Medicaid Services (CMS) which oversees Medicare, announced the first 10 Part D drugs selected for pricing negotiations, which will lead to revised prices in 2026.

The Trump administration is proposing a pay bump for physicians in 2026, alongside new reforms that align with the agency's ...

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since ...

CMS draft guidance includes Medicare Part B drugs in 2026 price negotiations, with new prices set for 2028. Public comment period on CMS proposal is open until June 26, 2025. From tariffs to ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next ...

In 2023, the Centers for Medicare and Medicaid Services (CMS) which oversees Medicare, announced the first 10 Part D drugs selected for pricing negotiations, which will lead to revised prices in 2026.

Medicare drug price negotiation is still relatively new. Until the 2022 passage of the Inflation Reduction Act, Medicare part D, which covers more than 50 million seniors , didn't have the ...

According to KFF’s research, the new Trump executive order on small molecule drugs could lead to higher Medicare prescription drug prices and potentially higher Medicare Part D premiums ...

Medicare drug price negotiation is still relatively new. Until the 2022 passage of the Inflation Reduction Act, Medicare part D, which covers more than 50 million seniors , didn't have the ...